• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Monday, June 8, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Omicron spreads faster and weakens jabs: WHO

Published on: December 13, 2021 11:17 AM

The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.

The Delta variant, first identified in India earlier this year, is responsible for most of the world’s coronavirus infections.

But South Africa’s discovery of Omicron — which has a large number of mutations — last month prompted countries around the world to impose travel bans on southern African countries and reintroduce domestic restrictions to slow its spread.

The WHO said Omicron had spread to 63 countries as of December 9. Faster transmission was noted in South Africa, where Delta is less prevalent, and in Britain, where Delta is the dominant strain.

But it stressed that a lack of data meant it could not say if Omicron’s rate of transmission was because it was less prone to immune responses, higher transmissibility or a combination of both.

Early evidence suggests Omicron causes “a reduction in vaccine efficacy against infection and transmission”, the WHO said in a technical brief.

“Given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs,” it added.

Omicron infections have so far caused “mild” illness or asymptomatic cases, but the WHO said the data was insufficient to establish the variant’s clinical severity.

South Africa reported Omicron to the WHO on November 24. Vaccine manufacturers Pfizer/BioNTech last week said three doses of their jabs were still effective against Omicron.

Countries with sufficient vaccine supplies such as Britain and France have encouraged their populations to receive a third “booster” jab to fight Omicron.

Filed Under: Health Tagged With: Latest

Submit a Comment




Primary Sidebar




Latest News

Mahira Khan reacts to acid attack on Quetta doctor, calls incident ‘barbaric’

Taylor Swift becomes richest female musician in history as net worth hits $2 billion

Lily Collins brings ‘Emily in Paris’ charm to French Open

Kim Kardashian cheers on Lewis Hamilton amid growing romance

Momina Iqbal’s rukhsati date revealed by sister

Pakistan

GB polling concludes peacefully: PPP, PML-N and PTI claim leads

Government warns against attempts to fuel unrest in AJK

Bilawal calls for dialogue to resolve AJK political crisis, meeting with PM likely

27 terrorists killed in North Waziristan IBOs: ISPR

Naqvi meets FM Araghchi, delivers CDF Munir’s message to Khamenei

More Posts from this Category

Business

Businesswomen call for economic inclusion, increased opportunities in budget discussions

OPEC+ agrees fourth oil quota hike since Hormuz closure

Global airlines slash 2026 profit forecast on fuel shock from Iran war

Economic pressure rises as joblessness hits record level, inflation shows no relief: BMP

‘FPCCI budget proposals can attract investment’

More Posts from this Category

World

Trump calls for more ‘surgical’ strikes against Hezbollah

42nd anniversary of Operation Blue Star: Stark reminder of Indian state’s tyranny towards Sikhs

Israel kills nine in Gaza as Egypt hosts new ceasefire talks

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.